google-site-verification: googlec7193c3de77668c9.html

A potential immunotherapy strategy for early-stage prostate cancer

[
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically “cold,” meaning they do not attract enough immune cells to mount a strong attack. Hormone therapy commonly used for prostate cancer, called androgen deprivation therapy (ADT), can temporarily make tumors more responsive by drawing immune cells into the cancer. But that benefit is short-lived: the treatment also increases levels of regulatory T cells (Tregs), which act as brakes on the immune system and blunt its anticancer effects.


Source link

Advertisements
Views: 2

See also  First measles death in Texas outbreak, plus surprising dementia drivers

Check Also

Cancer survivors and providers differ in views on medical cannabis, study finds

[ Credit: Unsplash/CC0 Public Domain For many cancer survivors, cannabis has become part of how …

Cutting-edge drug shows promise for patients with NRAS-driven melanoma

[ Credit: Unsplash/CC0 Public Domain A research team from Huntsman Cancer Institute at the University …

Q&A: Cyclospora outbreak

[ Credit: Sora Shimazaki from Pexels People across the United States are taking a closer …

Leave a Reply

Available for Amazon Prime